Pharmacokinetic and Pharmacodynamic Properties of Anti-VEGF Drugs After Intravitreal Injection

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|16|7|572-584

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.16, Iss.7, 2015-09, pp. : 572-584

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an overview

By Semeraro Francesco   Morescalchi Francesco   Duse Sarah   Gambicorti Elena   Romano Mario R   Costagliola Ciro  

Expert Opinion on Drug Safety, Vol. 13, Iss. 6, 2014-06 ,pp. : 785-802

Informa Healthcare

Access to resources Recommend Favorite

Clinical Pharmacokinetic and Pharmacodynamic Properties of Drugs Used in the Treatment of Parkinson's Disease

By Deleu D.  

Clinical Pharmacokinetics, Vol. 41, Iss. 4, 2002-01 ,pp. : 261-309

Adis International

Access to resources Recommend Favorite

Anti-VEGF Drugs in Eye Diseases: Local Therapy with Potential Systemic Effects

By  

Current Pharmaceutical Design, Vol. 21, Iss. 24, 2015-01 ,pp. : 3548-3556

Bentham Science Publishers

Access to resources Recommend Favorite

Resistance to Anti-VEGF Agents

By  

Current Pharmaceutical Design, Vol. 10, Iss. 1, 2004-01 ,pp. : 51-64

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic-Pharmacodynamic Relationships of the Anthracycline Anticancer Drugs

By Danesi R.  

Clinical Pharmacokinetics, Vol. 41, Iss. 6, 2002-01 ,pp. : 431-444

Adis International

Access to resources Recommend Favorite